The World of Health & Medicine News

Neuralink plans ‘high-volume’ brain implant production by 2026, Musk says

Neuralink plans ‘high-volume’ brain implant production by 2026, Musk says

Elon Musk’s brain implant company Neuralink will start “high-volume production” of brain-computer interface devices and move to an entirely automated surgical procedure in 2026, Musk said in a post on the social media platform X on Wednesday.

The implant is designed to help people with conditions such as a spinal cord injury. The first patient has used it to play video games, browse the internet, post on social media, and move a cursor on a laptop.

The company began human trials of its brain implant in 2024 after addressing safety concerns raised by the U.S. Food and Drug Administration, which had initially rejected its application in 2022.

Neuralink said in September that 12 people worldwide with severe paralysis have received its brain implants and were using them to control digital and physical tools through thought. It also secured $650 million in a June funding round.

spot_img

Explore more

spot_img

GSK enters lung cancer drug market with early FDA nod for...

GSK enters lung cancer drug market with early FDA nod for Jideytro GSK (GSK.L), opens new tab said on Wednesday the U.S. FDA approved its drug ​to...

Working from home could be harming your health, warns Chris Whitty

Working from home could be harming your health, warns Chris Whitty England’s chief medical officer has issued a warning about the health dangers of prolonged sitting, coinciding...

Popular sugar substitutes linked to faster brain aging

Popular sugar substitutes linked to faster brain aging Several popular sugar substitutes may not be as harmless as they seem. Adults who consumed the most...

 The Best Time to Eat Peaches for Energy, According to a...

The Best Time to Eat Peaches for Energy, According to a Dietitian Peaches are a juicy, naturally sweet, nutritious, and refreshing fruit. While there’s no...

FDA approves at-home starter dose of Eisai-Biogen Alzheimer’s drug

FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug The U.S. FDA on Monday approved an at-home starting dose of Eisai's (4523.T), opens new tab and Biogen's (BIIB.O),...

The One Healthy Food That Might be Spiking Your ‘Bad’ Cholesterol

The One Healthy Food That Might be Spiking Your 'Bad' Cholesterol Coconut oil has enjoyed a long run as a wellness favorite. It's been blended...

US FDA approves Vertex’s gene therapy for sickle cell disease in...

US FDA approves Vertex's gene therapy for sickle cell disease in children as young as two The U.S. Food and Drug Administration approved expanded use...

FDA clears Orca’s blood cancer therapy to reduce stem cell transplant...

FDA clears Orca's blood cancer therapy to reduce stem cell transplant complications The U.S. Food and Drug Administration said on ​Tuesday it has approved Orca...